Agenus maintains a global footprint as a result of collaborations and partnerships with foremost pharmaceutical and biotechnology companies in North The united states, Europe and Asia. Its agreements include analysis and development collaborations, license arrangements and co-growth systems aimed at accelerating the translation of novel immunothera